-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
One stage implant placement procedure: The pros and cons, a case report with literature review
Abhay Narayane K, Durgaraju M, Suresh Babu J, Phani L, Chowdary KRSS, Swarnalatha C
Case Report: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Bruce C Baguley
Review: Clinical Trail Outcomes: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
Information wants to be free; but when it comes to clinical trials, can we afford to let it?
Paul Wicks
Opinion Article: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation